110 participants
A Study of PCI-32765 (Ibrutinib) in Patients With Refractory Follicular Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2017-07-18
- Start Date:
- 2013-04-17
- Completion:
- 2016-05-18
Conditions
- Lymphoma
Interventions
- DRUG
No Results Yet